Recombinant fusion proteins of the porcine reproductive and respiratory syndrome virus (prrsv) and its use in diagnosis
CA 2276086 C · Owner: Inmunologia Y Genetica Alicada, S.A. · Inventors: Sanz Fernandez, Antonio; Casal Alvarez, Jose Ignacio; Rodriguez Garcia, Maria Jose
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The recombinant fusion proteins comprise the nucleocapside proteins of the porcine reproductive and respiratory syndrome virus (PRRSV) which has been , obtained both from a European isolate of PRRSV and from an American isolate and which was fused to an amino-acid sequence derived from the system selected for the expression of said recombinant fusion protein either directly or through a union region formed by a small number of amino-acids. Said recombinant fusion proteins are appropriate to be used in diagnosing PRRSV.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 24, 1997 and granted May 19, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 24, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 24, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.